Finanzwire Finanzwire
Basculer en Français
10653 Companies
226594 Keywords
155070 Articles
119968 Press releases
Headlines Articles Press releases Kedrion Remove
  1. Home
  2. Companies
  3. Kedrion
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/27/2025 at 10:10, 7 months 1 day ago

    EMA Grants Orphan Drug Designation to Kedrion's Treatment for ACP

    Biopharmaceutical Innovation Kedrion Orphan Drug EMA Approval Iron Metabolism
  • PRESS RELEASE

    published on 11/27/2025 at 10:05, 7 months 1 day ago

    European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism

    Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia granted Orphan Drug Designation by EMA, highlighting commitment to rare disease innovation
    Orphan Drug Designation Rare Disease Kedrion Plasma-derived Treatment Congenital Aceruloplasminemia
    Logo of Kedrion
  • BRIEF

    published on 11/06/2025 at 14:50, 7 months 22 days ago

    Kedrion Highlights Secondary Immunodeficiencies at IPIC 2025

    Kedrion Biopharma Hematologic Malignancies Secondary Immunodeficiencies IPIC 2025 Immunoglobulin Therapy
  • PRESS RELEASE

    published on 11/06/2025 at 14:45, 7 months 22 days ago

    Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care

    Kedrion Biopharma shines spotlight on Secondary Immunodeficiencies at IPIC 2025, highlighting challenges and advances in patient care
    Innovation Patient Care Kedrion Biopharma Secondary Immunodeficiencies IPIC 2025
    Logo of Kedrion
Accesswire
  • Published on 06/27/2026 at 16:50, 1 day 15 hours ago

    Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security

  • Published on 06/27/2026 at 01:40, 2 days 6 hours ago

    Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting

  • Published on 06/27/2026 at 00:00, 2 days 8 hours ago

    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

  • Published on 06/26/2026 at 23:00, 2 days 9 hours ago

    Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

  • Published on 06/26/2026 at 22:50, 2 days 9 hours ago

    Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE
EQS Group
  • Published on 06/29/2026 at 08:20, 13 minutes ago

    Eurobattery Minerals strengthens the Tungsten San Juan team for the next phase of industrial development

  • Published on 06/29/2026 at 08:10, 22 minutes ago

    Meeting Europe's Evolving Grid Needs: CHINT Highlights Its Resilient and Future-Ready Solutions for the AI Era at Intersolar Europe 2026

  • Published on 06/29/2026 at 08:05, 27 minutes ago

    Update on voluntary public offer by NNS for OCI

  • Published on 06/29/2026 at 08:00, 33 minutes ago

    MHM Corporate - General Meeting of June 30, 2026: likely to be held on second call due to lack of quorum

  • Published on 06/29/2026 at 08:00, 33 minutes ago

    Transaction in Own Shares

View all EQS
Les Echos
  • Published on 06/26/2026 at 17:45, 2 days 14 hours ago

    Combined General Meeting, June 25, 2026

  • Published on 06/26/2026 at 14:44, 2 days 17 hours ago

    Safran information

  • Published on 06/26/2026 at 07:00, 3 days 1 hour ago

    Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel

  • Published on 06/25/2026 at 17:50, 3 days 14 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 06/25/2026 at 07:30, 4 days 1 hour ago

    Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy